J Wang1, J Y Pan, B J Jia. 1. Department of Physiology, Sun Yat-sen University of Medical Sciences, Guangzhou 510089, China.
Abstract
AIM: To study the effects of L-arginine, a precursor for the synthesis of nitric oxide, when it was microinjected into the functionally identified depressor area in ventral surface of medulla oblongata (VSMd) on cardiovascular responses. METHODS: Artery pressure (AP), perfusion pressure of the kidney (PPK) and heart rate were recorded to study the effects of microinjection of NO related drugs into VSMd. RESULTS: (1) Unilateral microinjection of L-arginine (60 - 100 nmol) into VSMd produced prominent dose-related pressor effect and increased PPK but without significant changes in heart rate. (2) Microinjection of L-Arg (100 nmol) 3 min after microinjection of methylene blue (10 nmol) into VSMd did not significantly change AP and PPK. (3) Unilateral microinjection L-glutamate (350 nmol) into VSMd elicited depressor effect (-34.97% +/- 4.33%). The depressor effect was significantly dosed related attenuated by prior microinjection L-arginine (60 - 100 nmol) into the same area. CONCLUSION: These results suggest that the L-arginine - NO pathway in the VSMd participate in the central regulation of artery pressure and the pathway may have a key role in inhibiting glutamatergic neurotransmission in the anesthetized rats.
AIM: To study the effects of L-arginine, a precursor for the synthesis of nitric oxide, when it was microinjected into the functionally identified depressor area in ventral surface of medulla oblongata (VSMd) on cardiovascular responses. METHODS: Artery pressure (AP), perfusion pressure of the kidney (PPK) and heart rate were recorded to study the effects of microinjection of NO related drugs into VSMd. RESULTS: (1) Unilateral microinjection of L-arginine (60 - 100 nmol) into VSMd produced prominent dose-related pressor effect and increased PPK but without significant changes in heart rate. (2) Microinjection of L-Arg (100 nmol) 3 min after microinjection of methylene blue (10 nmol) into VSMd did not significantly change AP and PPK. (3) Unilateral microinjection L-glutamate (350 nmol) into VSMd elicited depressor effect (-34.97% +/- 4.33%). The depressor effect was significantly dosed related attenuated by prior microinjection L-arginine (60 - 100 nmol) into the same area. CONCLUSION: These results suggest that the L-arginine - NO pathway in the VSMd participate in the central regulation of artery pressure and the pathway may have a key role in inhibiting glutamatergic neurotransmission in the anesthetized rats.